BCL2L1 and breast carcinoma: We provide evidence for a role of the KRAS/BCL-XL interaction in the transition towards a CIC state together with the conceptual framework and tools to unravel its molecular basis, its regulation and biological outputs in breast cancer cell populations and CIC subsets.